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Arginine vasopressin, a potent vasoconstrictor and reg-
ulator of body water, is frequently increased in the plasma
of patients with congestive heart failure. Other neuro-
humoral control networks, such as the sympathetic ner-
vous system and the renin-angiot ensin system, also dem-
onstrate increased activity in congestive heart failure ,
but fail to respond normally to physiologic stress, such
as orthostatic tilt. To assess the response of plasma
vasopressin to orthostasis in heart failure, vasopressin
was measured before and at 10 and 45 minutes during
passive upright tilt in 15 patients with congestive heart
failure and their response was compared with that in 9
normal control subjects. Arginine vasopressin was mea-
sured by radioimmunoassay. In the normal subjects,
plasma arginine vasopressin was 5.3 ± 2.3 pg/ml at
Previous studies from our laboratory (1-3) demonstrated
that activi ties of neurohumoral control networks, such as
the sympathetic nervous system and the renin-angiotensin
system, ofte n are increased in patients with congestive heart
failure and that these systems often function abnormally in
response to stimuli such as orthostatic tilt and dynamic ex-
erc ise . In more recent investigat ions (4), we found that
circulating leve ls of arginine vasop ressin, a potent vasoco n-
strictor and regul ator of body water balance, also increase
in pat ients with conges tive heart failure . Because plasma
arginine vaso press in. like plasma norep inephrine and renin
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control, was unchanged at 10 minutes, but significantly
increased to 7.0 ± 2.5 pg/ml at 45 minutes (p < 0.05).
In contrast, patients with congestive heart failure showed
no significant changes in arginine vasopressin levelsfrom
the control levels of 11.6 ± 5.5 pg/ml. Both plasma
norepinephrine and renin activity increased in the nor-
mal subjects, but failed to increase from higher baselines
in patients with congestive heart failure.
Thus, plasma arginine vasopressin, like plasma nor-
epinephrine and renin activity, does not increase in re-
sponse t~ upright tilt in patients with congestive heart
failure. The explanation is not evident but could involve
either abnormalities in reflex control of plasma vaso-
pressin in congestive heart failure or in clearance of the
hormone during orthostasis.
acnvity, increases with orthostasis in normal individuals
(5-7). we undertook this study to inves tigate the response
of arginine vasopressin to this stimulus in patients with
conges tive heart failure .
Methods
Study patients. Two groups of patients were studied: 9
normal control subjects without evidence of heart failure or
hypertension and 15 patients with conges tive heart failure .
The normal control subjects were all men and ranged in age
from 37 to 72 years (mean 46) . The 15 patients had clea r
evidence of congestive heart failure on the basis of typical
findings on history and physical exam inat ion. The cause in
each case was either ischemic or primary cardiomyopathy.
Fourtee n of the patients were men and the group ranged in
age from 42 to 65 years (mean 53) . All individ uals were in
clinically stable condition at the time they were studied and
all were studied after being admitted to a cl inical research
unit where all diuretic and vasodilating drugs were withheld
for at least 48 hours to preclude meas uring drug effec ts .
The patients were maintained on a low sodium diet during
the time they were without medication. Electrolytes were
checked throughout the observation period and were within
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normal limits at the time of study. Serum sodium content
averaged 137 ± 2. 1 mEqlliter and although osmolality was
not measured, no patient had more than minor increases in
blood urea nitrogen and glucose.
Protocol. On the morning of the study. the patients re-
ported to a special procedures room where Swan-Ganzcath-
eters and arterial cannulas were placed by percutaneous
technique. Direct measurements of mean arterial pressure.
cardiac fill ing pressures and cardiac output by thermodilu-
tion were available, while heart rate was taken from an
electrocardiogram. At least 30 minutes after catheterization.
blood was sampled for vasopressin, as well as norepineph-
rine and renin activity. The patients were then tilted upright
on a tilt table to 65° for 45 minutes. Hemodynamic mea-
surements were made at 10 and 45 minutes during which
times blood was resampled for vasopressin. Norepinephrine
level was redetermined at 10 minutes and plasma renin
activity at 45 minutes. Osmolality was not determined. be-
cause it previously had been reported (5) not to change
during this duration and type of tilt protocol.
The normal subjects underwent an identical tilting pro-
tocol; however. hemodynamic measurements were confi ned
to heart rate from an electrocardiogram and blood pressure
as determined by standard cuff techniques.
Assays. All blood samples were collected into chilled
tubes and centrifuged immediately at 4°C. Plasma was re-
moved and frozen at - 20°C for later analysis. Vasopressin
levels were determined by a sensitive and specific radioim-
munoassay with a coefficient of variation under 4% (8).
Norepinephrine and plasma renin activity were determined
by radioenzymatic assay (Cat-a-Kit. Upjohn Corporation)
and radioimmunoassay (9). respectively. Both assays have
coefficients of variation under 8% in our laboratory.
Results were analyzed by an analysis of variance for
multiple measures on the same elements in the case of heart
rate. blood pressure and arginine vasopressin determina-
tions. Norepinephnne and plasma renin activity, for which
only two measurements were made, were analyzed by a
paired t test.
Plasma arginine vasopressin. Figure I displays the re-
sponse of plasma arginine vasopressin to the tilting proto-
col in normal subjects and Figure 2 displays the response
in patients with congestive heart failure. There was a small
but significant increase in plasma arginine vasopressin in
the normal subjects at 45 minutes (from 5.3 ± 2.3 to 7.0
± 2.5 pg/ml), although the 10minute value was notchanged.
In patients with congestive heart failure, the control level
of 11 .6 pgl ml did not change at either 10 or 45 minutes.
Plasma norepinephrine also increased in the normal subjects
(1 95 ± 75 to 350 ± 120pg/ml,p < 0.01). as did plasma
renin activity (1.9 ± 0.09 to 4.5 ± 3.4 nglml per hour, p
< 0.02). The patients with congestive heart failure had
higher rest levels (plasma norepinephrine 634 ± 432 pglml
and plasma renin activity 16 ± 13 nglml per hour) that did
not change during orthostatic tilt.
Discussion
The data from this study demonstrate that plasmaarginine
vasopressin levels. elevated in patients with congestive heart
failure. fail to increase in response to upright tilt. In this
respect, arginine vasopressin resembles plasma norepineph-
rine and renin activity, which also tend not to increase with
tilt in patients with congestive heart failure. If a large group
of patients with heart failure is studied, however, hetero-
geneity in response of plasma renin activity and norepi-
nephrine becomes apparent (3), and therefore it is still pos-
sible that if a larger experience were obtained, subgroups
of patients might be found in whom arginine vasopressin
does increase.
Abnormalities in reflex control of arginine vasopres-
sin. The explanation for the abnormal response of arginine
vasopressin to tilt in patients with congestive heart failure
is unclear. particularly because the mechanism of the in-
crease in normal subjects is also not well understood. The
increase in arginine vasopressin levels seen in normal sub-
jects in our study was less than that previously reported (5)
by investigators using a bioassay for arginine vasopressin
*p < 0.005 compared with control. Values are ± I standarddevianon.
Table 1. Heart Rate and Blood Pressure Response to
Upright Tilt
Results
Hemodynamics. Table I contains the response of heart
rate and arterial pressure to tilt in the two groups. Both
variables increased in the normal subjects, whereas neither
variable changed in patients with congestive heart failure.
These patients did, however. show decreases in right atrial
pressure (11 ± 6.6 to 6.3 ± 7 mm Hg, probability [pj <
0.001) and pulmonary capillary wedge pressure (25 ± 6.3
to 18 ± 11 mm Hg, p < 0.05). Cardiac index (2.1 ± 0.67
mllmin per nr') did not change significantly in the patients
with heart failure, but systemicvascular resistance increased
(1,573 ± 527 to 1,758 ± 522 dynes·s·cm- 5 • p < 0.05).
Study Group
Normal subjects (n = 9)
Heart rate (beats/min)
Mean arterial pressure (mm Hg)
Patients with congestive
heart failure (n = 15)
Heart rate (beats/min)
Mean arterial pressure (rnrn Hg)
10 45
Control Minutes Minutes
68 :t II 69 ± 10 75 ::!: 12*
89 :t 10 95 :!: 9* 98 ± 10*
82 ± 14 84 ± 17 86 ± 19
82 ± 6 81 ± 9 83 ± 7.3
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Figure 1. Response of plasma arginine e e
" "vasopressin (AVP) to 10 (a) and 45 (b) In InQ. Q.
minutes of upright tilt in normal subjects. 6 6
The45 minute value is significantly (p < ll. ll.> >




a c ia- b 1121' 45'
measurements, but was similar to their findings in that an
increase in arginine vasopressin was seen only after 45 min-
utes of orthostasis. The magnitude of response seen in our
study was, however, nearly identical to that found in two
earlier studies (6,7) in which arginine vasopressin levels
were measured by radioimmunoassay (assuming the usual
conversion of JLU/ml to pg/ml of 0,38 jLU/pg), In those
studies the increase in arginine vasopressin levels was also
apparent only after 45 minutes of tilt.
Previous investigators attributed the increase in arginine
vasopressin levels during tilt to "unloading" of low pressure
cardiopulmonary baroreceptors by the presumed decrease
in central venous pressure during this procedure, This as-
sumption was based on the prevailing concept derived from
many dog studies that modest changes in intracardiac pres-
sure do influence arginine vasopressin levels, However, in
a careful study (10) of the effects of selectively unloading
cardiopulmonary and sinoaortic baroreceptors in normal
subjects using lower body negative pressure, we found that
decreases in cardiopulmonary receptor tone alone did not
stimulate vasopressin. Unless hypotension occurred, argi-
nine vasopressinalso failed to increase in response to modest
unloadingof thesinoaorticbaroreceptor,Theseobservations,
plus the fact that vasopressin did not increase immediately
after tilting, may cast doubt on a reflex-based mechanism





Figure 2, Response of plasma arginine E e-,
"vasopressin (AVP) to 10 (a) and 45 (b) In 15 In ISQ. Q.
minutes of upright tilt in patients with
congestive heart failure. Differences are ll. ll.> >
not significant. a: a: ~10 11215 5 ..
if
0 0
a c 10' b 1121' 45'
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in arginine vasopressin with tilt in normal subjects could be
a result of more prolonged unloading of either or both of
these receptor groups. If so, then reflex control of arginine
vasopressin in patients with congestive heart failure may be
abnormal. Supporting this possibility are the observations
that sinoaortic baroreceptor function may be abnormal in
congestive heart failure in human beings (II), whereas car-
diopulmonary baroreceptor function may be abnormal in
animals with this condition (12). However, it is unlikely
that nonosmotic signals were simply overridden by an os-
motic stimulus during tilt, because serum sodium was nor-
mal at the outset and, as previously noted, osmolality does
not change during a brief orthostatic stress (5).
Abnormal response to changes in clearance of hor-
mone. Another explanation for the failure of arginine
vasopressin to increase during tilt in patients with congestive
heart failure may involve abnormalities in the clearance of
the hormone with the assumption of the upright posture.
Both the liver and the kidney are responsible for the me-
tabolism of arginine vasopressin (13). Few data are available
concerning the regional blood flow response to orthostasis
in patients with congestive heart failure, but we have re-
ported ( 14) that hepatic vascular resistance does not increase
during tilt as it does with normal individuals, and Lilly et
al. (15) reported that renal blood flow does not decrease in
at least some patients with congestive heart failure during
orthostasis. It is possible, therefore, that the absence of
dynamic changes in blood flow to these organs during tilt
could explain the lack of change in plasma arginine vaso-
pressin if decreased clearance were the mechanism respon-
sible for the increase in vasopressin in normal subjects.
Implications. The biologic importance of the absence
of change in vasopressin during tilt in congestive heart fail-
ure is unclear. Vasopressin levels in the physiologic range
can affect both the total and regional vascular resistance in
animals (16,17). We do not yet know whether levels in the
range in our study have actual circulatory effects in patients
with congestive heart failure. Theoretically, however, the
absence of change in vasopressin during tilt, together with
that of sympathetic nervous system activity and renin, could
explain, in part, the abnormal regional blood flow response
to orthostasis in this condition (14,15) if the normal increase
in forearm, hepatic and renal vascular resistance during
orthostasis depends on an increase in the activity of any of
these neurohumoral controllers.
In summary. this study has shown that the response of
vasopressin to orthostatic tilt, like that of plasma norepi-
nephrine and plasma renin activity, is blunted in patients
with congestive heart failure. Mechanisms could involve
either abnormalities in reflex control of arginine vasopressin
or abnormalities in clearance of the hormone during this
maneuver. These observations add to the picture of gen-
eralized disturbances in important neurohumoral control
mechanisms of the peripheral circulation both at rest and
with stress in patients with congestive heart failure.
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